AI-Enhanced ECG Predicts Hypertension, Related Risks
An artificial intelligence–ECG risk estimation model designed to predict incident hypertension (AIRE-HTN) identifies cases and stratifies the risk for adverse outcomes in addition to traditional markers.
CGM Use, GLP-1s, Drinking Water Key of 2025 ADA Standards
The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) beyond weight loss, management of metabolic dysfunction-associated liver disease (MAFLD), plus a strong endorsement for drinking water and much more.
ADA Advises Against Using Compounded GLP-1 RA Medications
In a new statement, the American Diabetes Association (ADA) has advised against the use of compounded glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RA medication classes.
New Trial Result Pushes Past Antiarrhythmic Therapy After MI
For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy, which is typically used first, the multinational VANISH2 trial shows.
New Pill Successfully Lowers Lp(a) Levels
Muvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 KRAKEN trial show.
The results of the 35th International Congress of Cardiology "Great Wall" and the Asian Congress of Cardiology 2024
The anniversary 35th International Congress of Cardiology "Great Wall" and the Asian Congress of Cardiology were held in Beijing at the National Exhibition Center on November 7-10, 2024.
As part of the four-day congress, 415 scientific sessions were organized and 2177 reports were made on various areas of cardiology. The congress was attended by 23,980 national and international experts, professors and specialists from almost 40 countries from all the continents of the world.
New State Law Will Restrict AI in Prior Authorization, Coverage Decisions
California is taking aim at algorithms used by insurers to make prior authorization and other coverage decisions with a new law that will put limitations on how artificial intelligence (AI)–generated formulas are employed.
Development and validation of a machine learning model to predict myocardial blood flow and clinical outcomes from patients’ electrocardiograms
Scientists have developed a machine learning (ML) model using electrocardiography (ECG) to predict myocardial blood flow reserve (MFR) and assess its predictive value in relation to major adverse cardiovascular events (MACEs). Using 3639 ECG positron emission tomography (PET) and 17,649 pairs of ECG single-photon emission computed tomography data (SPECT), the model is trained using the intelligent swarm intelligence approach and support vector regression (SVR).
New Scanner Creates Highly Detailed, 3D Images of Blood Vessels in Just Seconds
A new scanner can provide three-dimensional (3D) photoacoustic images of millimeter-scale veins and arteries in seconds.
Nobel Prize in medicine goes to two American biologists for work on the discovery of microRNA
The 2024 Nobel Prize in physiology or medicine has been awarded to US scientists Victor Ambros and Gary Ruvkun for their work on the discovery of microRNA, a molecule that governs how cells in the body function.